{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:33:20Z","timestamp":1789551200987,"version":"build-2803163510"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00203-026-04721-z","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:13:22Z","timestamp":1770020002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic milestones against multidrug resistant Acinetobacter baumannii: from legacy antibiotics to Zosurabalpin"],"prefix":"10.1007","volume":"208","author":[{"given":"Jaya","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpy","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmsheel","family":"Shrivastav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ved Vrat","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Kant","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8575-6939","authenticated-orcid":false,"given":"Varun Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"4721_CR1","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/phar.2476","volume":"40","author":"JC Abdul-Mutakabbir","year":"2020","unstructured":"Abdul-Mutakabbir JC, Alosaimy S, Morrisette T, Kebriaei R, Rybak MJ (2020) Cefiderocol: A novel siderophore cephalosporin against multidrug-resistant Gram-negative pathogens. Pharmacotherapy 40:1228\u20131247. https:\/\/doi.org\/10.1002\/phar.2476","journal-title":"Pharmacotherapy"},{"key":"4721_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11169-x","volume":"25","author":"FM Adeyemi","year":"2025","unstructured":"Adeyemi FM, Akinlade EA, Yusuf-Omoloye NA, Ajigbewu OH, Dare AP, Wahab AA, Oyedara OO, Isiaka HS, Usamat AO (2025) Carbapenem-resistance in Acinetobacter baumannii: prevalence, antibiotic resistance profile and carbapenemase genes in clinical and hospital environmental strains. BMC Infect Dis 25:786. https:\/\/doi.org\/10.1186\/s12879-025-11169-x","journal-title":"BMC Infect Dis"},{"key":"4721_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10393-025-01752-8","author":"UM Afoma","year":"2025","unstructured":"Afoma UM, Singh S, Mishra AK, Sharma CK, Gupta K, Mishra MK, Roy B, Verma VV, Sharma VK (2025) Integrating artificial intelligence in environmental monitoring: a paradigm shift in data-driven sustainability. Eco Health. https:\/\/doi.org\/10.1007\/s10393-025-01752-8","journal-title":"Eco Health"},{"key":"4721_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12040644","volume":"12","author":"OE Ahuatzin-Flores","year":"2024","unstructured":"Ahuatzin-Flores OE, Torres E, Ch\u00e1vez-Bravo E (2024) Acinetobacter baumannii, a multidrug-resistant opportunistic pathogen in new habitats: A systematic review. Microorganisms 12:644. https:\/\/doi.org\/10.3390\/microorganisms12040644","journal-title":"Microorganisms"},{"key":"4721_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/ph15040476","volume":"15","author":"S Alfei","year":"2022","unstructured":"Alfei S, Schito AM (2022) \u03b2-Lactam antibiotics and \u03b2-lactamase enzyme inhibitors, part 2: our limited resources. Pharmaceuticals 15:476. https:\/\/doi.org\/10.3390\/ph15040476","journal-title":"Pharmaceuticals"},{"key":"4721_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083905","volume":"22","author":"R Aminov","year":"2021","unstructured":"Aminov R (2021) Acquisition and spread of antimicrobial resistance: A tet(X) case study. Int J Mol Sci 22:3905. https:\/\/doi.org\/10.3390\/ijms22083905","journal-title":"Int J Mol Sci"},{"key":"4721_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/978-981-33-6009-9_55","volume-title":"Introduction to Basics of Pharmacology and Toxicology: Volume 2 \u2013 Essentials of Systemic Pharmacology: From Principles to Practice","author":"N Anandabaskar","year":"2021","unstructured":"Anandabaskar N (2021) Protein synthesis inhibitors. In: Paul A, Anandabaskar N, Mathaiyan J, Raj GM (eds) Introduction to Basics of Pharmacology and Toxicology: Volume 2 \u2013 Essentials of Systemic Pharmacology: From Principles to Practice. Springer Nature, pp 835\u2013868. https:\/\/doi.org\/10.1007\/978-981-33-6009-9_55"},{"key":"4721_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14787210.2023.2184346","volume":"21","author":"A Ardebili","year":"2023","unstructured":"Ardebili A, Izanloo A, Rastegar M (2023) Polymyxin combination therapy for multidrug-resistant, extensively drug-resistant, and difficult-to-treat drug-resistant Gram-negative infections: is it superior to polymyxin monotherapy? Expert Rev Anti-Infect Ther 21:387\u2013429. https:\/\/doi.org\/10.1080\/14787210.2023.2184346","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"4721_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/antibiotics11030421","volume":"11","author":"C Aurilio","year":"2022","unstructured":"Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, Barbarisi A, Passavanti MB, Pace MC (2022) Mechanisms of action of carbapenem resistance. Antibiotics 11:421. https:\/\/doi.org\/10.3390\/antibiotics11030421","journal-title":"Antibiotics"},{"key":"4721_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9030119","volume":"9","author":"C Ayoub Moubareck","year":"2020","unstructured":"Ayoub Moubareck C, Hammoudi Halat D (2020) Insights into Acinetobacter baumannii: A review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics 9:119. https:\/\/doi.org\/10.3390\/antibiotics9030119","journal-title":"Antibiotics"},{"key":"4721_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101313","volume":"297","author":"T Baeta","year":"2021","unstructured":"Baeta T, Giandoreggio-Barranco K, Ayala I, Moura ECCM, Sperandeo P, Polissi A, Simorre JP, Laguri C (2021) The lipopolysaccharide-transporter complex LptB2FG also displays adenylate kinase activity in vitro dependent on the binding partners LptC\/LptA. J Biol Chem 297:101313. https:\/\/doi.org\/10.1016\/j.jbc.2021.101313","journal-title":"J Biol Chem"},{"key":"4721_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40121-022-00597-w","volume":"11","author":"C Bartal","year":"2022","unstructured":"Bartal C, Rolston KVI, Nesher L (2022) Carbapenem-resistant Acinetobacter baumannii: colonization, infection and current treatment options. Infect Dis Ther 11:683\u2013694. https:\/\/doi.org\/10.1007\/s40121-022-00597-w","journal-title":"Infect Dis Ther"},{"key":"4721_CR13","doi-asserted-by":"publisher","DOI":"10.56294\/hl2024.383","volume":"3","author":"KL Behera","year":"2024","unstructured":"Behera KL, Taneja M, Faiz A, Hanumanthayya M, Sharma VK, Kore N, Antony M (2024) Environmental health interventions and their impact on quality of life. Health Leadersh Qual Life 3:383. https:\/\/doi.org\/10.56294\/hl2024.383","journal-title":"Health Leadersh Qual Life"},{"key":"4721_CR14","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.48047\/mk3jsc21","volume":"54","author":"AU Bulakarima","year":"2025","unstructured":"Bulakarima AU, Sharma VK, Singh S, Isa MA, Dudha N (2025) Investigating the antibacterial and antioxidant properties of Zingiber officinale (ginger) extracts. Cuestiones Fisioter 54:4449\u20134471. https:\/\/doi.org\/10.48047\/mk3jsc21","journal-title":"Cuestiones Fisioter"},{"key":"4721_CR15","doi-asserted-by":"publisher","first-page":"13952","DOI":"10.1021\/acs.chemrev.1c01035","volume":"122","author":"K Cai","year":"2022","unstructured":"Cai K, Zhang X, Bai X (2022) Cryo-electron microscopic analysis of single-pass transmembrane receptors. Chem Rev 122:13952\u201313988. https:\/\/doi.org\/10.1021\/acs.chemrev.1c01035","journal-title":"Chem Rev"},{"key":"4721_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011520","volume":"19","author":"AK Cain","year":"2023","unstructured":"Cain AK, Hamidian M (2023) Portrait of a killer: uncovering resistance mechanisms and global spread of Acinetobacter baumannii. PLoS Pathog 19:e1011520. https:\/\/doi.org\/10.1371\/journal.ppat.1011520","journal-title":"PLoS Pathog"},{"key":"4721_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03343-24","volume":"16","author":"L Capodimonte","year":"2025","unstructured":"Capodimonte L, Meireles FTP, Bahr G, Bonomo RA, Dal Peraro M, L\u00f3pez C, Vila AJ (2025) OXA \u03b2-lactamases from Acinetobacter spp. are membrane bound and secreted into outer membrane vesicles. mBio 16:e0334324. https:\/\/doi.org\/10.1128\/mbio.03343-24","journal-title":"mBio"},{"key":"4721_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/antibiotics10080995","volume":"10","author":"D Carcione","year":"2021","unstructured":"Carcione D, Siracusa C, Sulejmani A, Leoni V, Intra J (2021) Old and new beta-lactamase inhibitors: molecular structure, mechanism of action, and clinical use. Antibiotics 10:995. https:\/\/doi.org\/10.3390\/antibiotics10080995","journal-title":"Antibiotics"},{"key":"4721_CR19","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1093\/cid\/ciad109","volume":"76","author":"M Castanheira","year":"2023","unstructured":"Castanheira M, Mendes RE, Gales AC (2023) Global epidemiology and mechanisms of resistance of Acinetobacter baumannii\u2013calcoaceticus complex. Clin Infect Dis 76:S166\u2013S178. https:\/\/doi.org\/10.1093\/cid\/ciad109","journal-title":"Clin Infect Dis"},{"key":"4721_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001878","volume":"20","author":"AD Chiang","year":"2022","unstructured":"Chiang AD, Patil PP, Beka L, Youn JH, Launay A, Bonomo RA, Khil PP, Dekker JP (2022) Hypermutator strains of Pseudomonas aeruginosa reveal novel pathways of resistance to combinations of cephalosporin antibiotics and beta-lactamase inhibitors. PLoS Biol 20:e3001878. https:\/\/doi.org\/10.1371\/journal.pbio.3001878","journal-title":"PLoS Biol"},{"key":"4721_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010121","volume":"17","author":"F Ciftci","year":"2025","unstructured":"Ciftci F, \u00d6zarslan AC, Kantarci \u0130C, Yelkenci A, Tavukcuoglu O, Ghorbanpour M (2025) Advances in drug targeting, drug delivery, and nanotechnology applications: therapeutic significance in cancer treatment. Pharmaceutics 17:121. https:\/\/doi.org\/10.3390\/pharmaceutics17010121","journal-title":"Pharmaceutics"},{"key":"4721_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.884365","volume":"12","author":"F Cruz-L\u00f3pez","year":"2022","unstructured":"Cruz-L\u00f3pez F, Mart\u00ednez-Mel\u00e9ndez A, Morfin-Otero R, Rodriguez-Noriega E, Maldonado-Garza HJ, Garza-Gonz\u00e1lez E (2022) Efficacy and in vitro activity of novel antibiotics for infections with carbapenem-resistant Gram-negative pathogens. Front Cell Infect Microbiol 12:884365. https:\/\/doi.org\/10.3389\/fcimb.2022.884365","journal-title":"Front Cell Infect Microbiol"},{"key":"4721_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.18683\/germs.2022.1328","volume":"12","author":"R Dehbanipour","year":"2022","unstructured":"Dehbanipour R, Ghalavand Z (2022) Anti-virulence therapeutic strategies against bacterial infections: recent advances. Germs 12:262\u2013275. https:\/\/doi.org\/10.18683\/germs.2022.1328","journal-title":"Germs"},{"key":"4721_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10661-025-14786-w","volume":"197","author":"A Devi","year":"2025","unstructured":"Devi A, Sharma VK, Shrivastav D, Singh S (2025) The environmental threat of macrolide resistance: mechanisms, dissemination pathways, and urgent mitigation strategies. Environ Monit Assess 197:1318. https:\/\/doi.org\/10.1007\/s10661-025-14786-w","journal-title":"Environ Monit Assess"},{"key":"4721_CR25","doi-asserted-by":"publisher","first-page":"15767","DOI":"10.1021\/acs.chemrev.0c01321","volume":"122","author":"F Di Lorenzo","year":"2022","unstructured":"Di Lorenzo F, Duda KA, Lanzetta R, Silipo A, De Castro C, Molinaro A (2022) A journey from structure to function of bacterial lipopolysaccharides. Chem Rev 122:15767\u201315821. https:\/\/doi.org\/10.1021\/acs.chemrev.0c01321","journal-title":"Chem Rev"},{"key":"4721_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/MRM.0000000000000235","volume":"32","author":"B Douzandeh-Mobarrez","year":"2021","unstructured":"Douzandeh-Mobarrez B, Alizade H, Kafil HS, Karmostaji A (2021) Antimicrobial categories in describing multidrug resistance, extensive drug resistance and pan-drug resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: a systematic review. Rev Med Microbiol 32:6\u201311. https:\/\/doi.org\/10.1097\/MRM.0000000000000235","journal-title":"Rev Med Microbiol"},{"key":"4721_CR27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s12088-024-01293-8","volume":"64","author":"S Dubey","year":"2024","unstructured":"Dubey S, Siddiqui AH, Sharma M (2024) The impact of fosfomycin on Gram-negative infections: a comprehensive review. Indian J Microbiol 64:846\u2013858. https:\/\/doi.org\/10.1007\/s12088-024-01293-8","journal-title":"Indian J Microbiol"},{"key":"4721_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/2025.07.07.663478","author":"E Dunbar","year":"2025","unstructured":"Dunbar E, Clark R, Basl\u00e9 A, Allyjaun S, Newman H, Hubbard J, van den Berg B (2025) Small siphophage binding to an open state of the LptDE outer membrane lipopolysaccharide translocon. bioRxiv. https:\/\/doi.org\/10.1101\/2025.07.07.663478","journal-title":"bioRxiv"},{"key":"4721_CR29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/phar.2802","volume":"43","author":"A El-Ghali","year":"2023","unstructured":"El-Ghali A, Kunz Coyne AJ, Caniff K, Bleick C, Rybak MJ (2023) Sulbactam-durlobactam: a novel \u03b2-lactam\u2013\u03b2-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections. Pharmacotherapy 43:502\u2013513. https:\/\/doi.org\/10.1002\/phar.2802","journal-title":"Pharmacotherapy"},{"issue":"Suppl 2","key":"4721_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.1733","volume":"10","author":"I Erbetti","year":"2023","unstructured":"Erbetti I, Ferrari L, Ortombina A, Savoia P, Felici A, Bissantz C, Zampaloni C (2023) In vitro and in vivo killing kinetics of Zosurabalpin (RG6006) against Acinetobacter baumannii. Open Forum Infect Dis 10(Suppl 2):ofad500.1733. https:\/\/doi.org\/10.1093\/ofid\/ofad500.1733","journal-title":"Open Forum Infect Dis"},{"key":"4721_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106221","volume":"182","author":"Z Ezzeddine","year":"2023","unstructured":"Ezzeddine Z, Ghssein G (2023) Towards new antibiotics classes targeting bacterial metallophores. Microb Pathog 182:106221. https:\/\/doi.org\/10.1016\/j.micpath.2023.106221","journal-title":"Microb Pathog"},{"key":"4721_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1021\/acsinfecdis.4c00880","volume":"11","author":"I Faheem","year":"2025","unstructured":"Faheem I, Nagaraja V (2025) Multifunctional mycobacterial topoisomerases with distinctive features. ACS Infect Dis 11:366\u2013385. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00880","journal-title":"ACS Infect Dis"},{"key":"4721_CR33","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.7573\/dic.2021-8-9","volume":"11","author":"A FakhriRavari","year":"2022","unstructured":"FakhriRavari A, Simiyu B, Morrisette T, Dayo Y, Abdul-Mutakabbir JC (2022) Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy. Drugs Context 11:2021\u20132028. https:\/\/doi.org\/10.7573\/dic.2021-8-9","journal-title":"Drugs Context"},{"key":"4721_CR34","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3390\/molecules26072047","volume":"26","author":"M Ferreira","year":"2021","unstructured":"Ferreira M, Ogren M, Dias JNR, Silva M, Gil S, Tavares L, Aires-da-Silva F, Gaspar MM, Aguiar SI (2021) Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance. Molecules 26:2047. https:\/\/doi.org\/10.3390\/molecules26072047","journal-title":"Molecules"},{"key":"4721_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14050490","volume":"14","author":"F Foglia","year":"2025","unstructured":"Foglia F, Ambrosino A, Bashir S, Finamore E, Zannella C, Donnarumma G, De Filippis A, Galdiero M (2025) Prevalence of Acinetobacter baumannii multidrug resistance in university hospital environment. Antibiotics 14:490. https:\/\/doi.org\/10.3390\/antibiotics14050490","journal-title":"Antibiotics"},{"key":"4721_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/antibiotics14030221","volume":"14","author":"I Gajic","year":"2025","unstructured":"Gajic I, Tomic N, Lukovic B, Jovicevic M, Kekic D, Petrovic M, Jankovic M, Trudic A, Mitic Culafic D, Milenkovic M, Opavski N (2025) A comprehensive overview of antibacterial agents for combating multidrug-resistant bacteria: the current landscape, development, future opportunities, and challenges. Antibiotics 14:221. https:\/\/doi.org\/10.3390\/antibiotics14030221","journal-title":"Antibiotics"},{"key":"4721_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14030222","volume":"14","author":"M Galgano","year":"2025","unstructured":"Galgano M, Pellegrini F, Catalano E, Capozzi L, Del Sambro L, Sposato A, Lucente MS, Vasinioti VI, Catella C, Odigie AE, Tempesta M, Pratelli A, Capozza P (2025) Acquired bacterial resistance to antibiotics and resistance genes: from past to future. Antibiotics 14:222. https:\/\/doi.org\/10.3390\/antibiotics14030222","journal-title":"Antibiotics"},{"key":"4721_CR38","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2020.0462","volume":"377","author":"TM Ghaly","year":"2021","unstructured":"Ghaly TM, Gillings MR (2021) New perspectives on mobile genetic elements: a paradigm shift for managing the antibiotic resistance crisis. Philos Trans R Soc Lond B Biol Sci 377:20200462. https:\/\/doi.org\/10.1098\/rstb.2020.0462","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"4721_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-024-04146-9","volume":"14","author":"K Gupta","year":"2024","unstructured":"Gupta K, Sharma VK (2024) Cutting-edge perspectives on biosurfactants: implications for antimicrobial and biomedical applications. 3 Biotech 14:297. https:\/\/doi.org\/10.1007\/s13205-024-04146-9","journal-title":"3 Biotech"},{"key":"4721_CR40","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1039\/D0CS00729C","volume":"50","author":"B Ha Gan","year":"2021","unstructured":"Ha Gan B, Gaynord J, Rowe SM, Deingruber T, Spring DR (2021) The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem Soc Rev 50:7820\u20137880. https:\/\/doi.org\/10.1039\/D0CS00729C","journal-title":"Chem Soc Rev"},{"key":"4721_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40121-020-00395-2","volume":"10","author":"GT Hansen","year":"2021","unstructured":"Hansen GT (2021) Continuous evolution: perspective on the epidemiology of carbapenemase resistance among Enterobacterales and other Gram-negative bacteria. Infect Dis Ther 10:75\u201392. https:\/\/doi.org\/10.1007\/s40121-020-00395-2","journal-title":"Infect Dis Ther"},{"key":"4721_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.1754","volume":"10","author":"S Hawser","year":"2023","unstructured":"Hawser S, Kothari N, Valmont T, Louvel S, Zampaloni C (2023) Activity of the novel antibiotic Zosurabalpin (RG6006) against clinical Acinetobacter isolates from China. Open Forum Infect Dis 10:ofad500.1754. https:\/\/doi.org\/10.1093\/ofid\/ofad500.1754","journal-title":"Open Forum Infect Dis"},{"key":"4721_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020206","volume":"18","author":"YS Huang","year":"2025","unstructured":"Huang YS, Zhou H (2025) Breakthrough advances in beta-lactamase inhibitors: new synthesized compounds and mechanisms of action against drug-resistant bacteria. Pharmaceuticals 18:206. https:\/\/doi.org\/10.3390\/ph18020206","journal-title":"Pharmaceuticals"},{"key":"4721_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/antibiotics11040520","volume":"11","author":"L Huang","year":"2022","unstructured":"Huang L, Wu C, Gao H, Xu C, Dai M, Huang L, Hao H, Wang X, Cheng G (2022) Bacterial multidrug efflux pumps at the frontline of antimicrobial resistance: an overview. Antibiotics 11:520. https:\/\/doi.org\/10.3390\/antibiotics11040520","journal-title":"Antibiotics"},{"key":"4721_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40265-024-02104-6","volume":"85","author":"A Iovleva","year":"2025","unstructured":"Iovleva A, Fowler VG Jr, Doi Y (2025) Treatment approaches for carbapenem-resistant Acinetobacter baumannii infections. Drugs 85:21\u201340. https:\/\/doi.org\/10.1007\/s40265-024-02104-6","journal-title":"Drugs"},{"key":"4721_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci9110650","volume":"9","author":"W Jansen","year":"2022","unstructured":"Jansen W, van Hout J, Wiegel J, Iatridou D, Chantziaras I, De Briyne N (2022) Colistin use in European livestock: veterinary field data on trends and perspectives for further reduction. Vet Sci 9:650. https:\/\/doi.org\/10.3390\/vetsci9110650","journal-title":"Vet Sci"},{"key":"4721_CR47","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1080\/14787210.2024.2412637","volume":"22","author":"SS Jean","year":"2024","unstructured":"Jean SS, Liu CY, Huang TY, Lai CC, Liu IM, Hsieh PC, Hsueh PR (2024) Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future? Expert Rev Anti Infect Ther 22:1171\u20131187. https:\/\/doi.org\/10.1080\/14787210.2024.2412637","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4721_CR48","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S1473-3099(23)00184-6","volume":"23","author":"KS Kaye","year":"2023","unstructured":"Kaye KS, Shorr AF, Wunderink RG, Du B, Poirier GE, Rana K, Miller A, Lewis D, O\u2019Donnell J, Chen L, Reinhart H, Srinivasan S, Isaacs R, Altarac D (2023) Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii\u2013calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK). Lancet Infect Dis 23:1072\u20131084. https:\/\/doi.org\/10.1016\/S1473-3099(23)00184-6","journal-title":"Lancet Infect Dis"},{"key":"4721_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12050813","volume":"12","author":"SY Ko","year":"2023","unstructured":"Ko SY, Kim N, Park SY, Kim SY, Shin M, Lee JC (2023) Acinetobacter baumannii under acidic conditions induces colistin resistance through PmrAB activation and lipid A modification. Antibiotics 12:813. https:\/\/doi.org\/10.3390\/antibiotics12050813","journal-title":"Antibiotics"},{"key":"4721_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00514-21","volume":"65","author":"V Kornelsen","year":"2021","unstructured":"Kornelsen V, Kumar A (2021) Update on multidrug resistance efflux pumps in Acinetobacter spp. Antimicrob Agents Chemother 65:e0051421. https:\/\/doi.org\/10.1128\/AAC.00514-21","journal-title":"Antimicrob Agents Chemother"},{"key":"4721_CR51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/biom14070783","volume":"14","author":"D Kounatidis","year":"2024","unstructured":"Kounatidis D, Dalamaga M, Grivakou E, Karampela I, Koufopoulos P, Dalopoulos V, Adamidis N, Mylona E, Kaziani A, Vallianou NG (2024) Third-generation tetracyclines: current knowledge and therapeutic potential. Biomolecules 14:783. https:\/\/doi.org\/10.3390\/biom14070783","journal-title":"Biomolecules"},{"key":"4721_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-024-00790-3","volume":"213","author":"E Krzy\u017cewska-Dudek","year":"2024","unstructured":"Krzy\u017cewska-Dudek E, Dulipati V, Kapczy\u0144ska K, Noszka M, Chen C, Kotimaa J, Ksi\u0105\u017cczyk M, Dudek B, Bugla-P\u0142osko\u0144ska G, Pawlik K, Meri S, Rybka J (2024) Lipopolysaccharide with long O-antigen is crucial for Salmonella Enteritidis to evade complement activity and to facilitate bacterial survival in vivo in the Galleria mellonella infection model. Med Microbiol Immunol 213:8. https:\/\/doi.org\/10.1007\/s00430-024-00790-3","journal-title":"Med Microbiol Immunol"},{"key":"4721_CR53","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1093\/jac\/dkac248","volume":"77","author":"WD Kufel","year":"2022","unstructured":"Kufel WD, Abouelhassan Y, Steele JM, Gutierrez RL, Perwez T, Bourdages G, Nicolau DP (2022) Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis. J Antimicrob Chemother 77:2737\u20132741. https:\/\/doi.org\/10.1093\/jac\/dkac248","journal-title":"J Antimicrob Chemother"},{"key":"4721_CR54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1039\/d4md00745j","volume":"16","author":"G Kumar","year":"2024","unstructured":"Kumar G (2024) Natural peptides and their synthetic congeners acting against Acinetobacter baumannii through the membrane and cell wall: latest progress. RSC Med Chem 16:561\u2013604. https:\/\/doi.org\/10.1039\/d4md00745j","journal-title":"RSC Med Chem"},{"key":"4721_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9102104","volume":"9","author":"S Kumar","year":"2021","unstructured":"Kumar S, Anwer R, Azzi A (2021) Virulence potential and treatment options of multidrug-resistant (MDR) Acinetobacter baumannii. Microorganisms 9:2104. https:\/\/doi.org\/10.3390\/microorganisms9102104","journal-title":"Microorganisms"},{"key":"4721_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10030373","volume":"10","author":"I Kyriakidis","year":"2021","unstructured":"Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A (2021) Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens 10:373. https:\/\/doi.org\/10.3390\/pathogens10030373","journal-title":"Pathogens"},{"key":"4721_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118007","volume":"186","author":"X Li","year":"2025","unstructured":"Li X, Dong S, Pan Q, Liu N, Zhang Y (2025) Antibiotic conjugates: using molecular Trojan horses to overcome drug resistance. Biomed Pharmacother 186:118007. https:\/\/doi.org\/10.1016\/j.biopha.2025.118007","journal-title":"Biomed Pharmacother"},{"key":"4721_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2024.113952","volume":"178","author":"YY Liu","year":"2024","unstructured":"Liu YY, Lu L, Yue C, Gao X, Chen J, Gao G, Liu JH (2024) Emergence of plasmid-mediated high-level tigecycline resistance gene <Emphasis Type=\"Italic\">tet(X4)<\/Emphasis> in <Emphasis Type=\"Italic\">Enterobacterales<\/Emphasis> from retail aquatic products. Food Res Int 178:113952. https:\/\/doi.org\/10.1016\/j.foodres.2024.113952","journal-title":"Food Res Int"},{"key":"4721_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s40203-025-00343-3","volume":"13","author":"M Magri","year":"2025","unstructured":"Magri M, Eljaoudi R, Belyamani L, Ibrahimi A, Bouricha EM (2025) In silico analysis of zosurabalpin\u2013LptB2FG binding in Acinetobacter spp., Klebsiella pneumoniae, and Shigella flexneri: mechanisms underlying its differential efficacy. In Silico Pharmacol 13:62. https:\/\/doi.org\/10.1007\/s40203-025-00343-3","journal-title":"In Silico Pharmacol"},{"key":"4721_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s12223-025-01356-3","author":"J Malik","year":"2025","unstructured":"Malik J, Naushad Z, Singh S, Shrivastav D, Verma VV, Mishra MK, Pal RK, Sharma VK (2025) Emerging contaminants in healthcare effluents: antibiotic resistance and virulence factor dissemination. Folia Microbiol. https:\/\/doi.org\/10.1007\/s12223-025-01356-3","journal-title":"Folia Microbiol"},{"key":"4721_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11081912","volume":"11","author":"G Mancuso","year":"2023","unstructured":"Mancuso G, De Gaetano S, Midiri A, Zummo S, Biondo C (2023) The challenge of overcoming antibiotic resistance in carbapenem-resistant Gram-negative bacteria: \u201cAttack on Titan.\u201d Microorganisms 11:2023. https:\/\/doi.org\/10.3390\/microorganisms11081912","journal-title":"Microorganisms"},{"key":"4721_CR62","doi-asserted-by":"publisher","first-page":"e0020923","DOI":"10.1128\/spectrum.00209-23","volume":"11","author":"D Mangioni","year":"2023","unstructured":"Mangioni D, Fox V, Chatenoud L, Bolis M, Bottino N, Cariani L, Gentiloni Silverj F, Matinato C, Monti G, Muscatello A, Teri A, Terranova L, Piatti A, Gori A, Grasselli G, Stocchetti N, Alteri C, Bandera A (2023) Genomic characterization of carbapenem-resistant Acinetobacter baumannii (CRAB) in mechanically ventilated COVID-19 patients and impact of infection control measures on reducing CRAB circulation during the second wave of the SARS-CoV-2 pandemic in Milan, Italy. Microbiol Spectr 11:e0020923. https:\/\/doi.org\/10.1128\/spectrum.00209-23","journal-title":"Microbiol Spectr"},{"key":"4721_CR63","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.3390\/ijms25136814","volume":"25","author":"A Marino","year":"2024","unstructured":"Marino A, Augello E, Stracquadanio S, Bellanca CM, Cosentino F, Spampinato S, Cantarella G, Bernardini R, Stefani S, Cacopardo B, Nunnari G (2024) Unveiling the secrets of Acinetobacter baumannii: Resistance, current treatments, and future innovations. Int J Mol Sci 25:6814. https:\/\/doi.org\/10.3390\/ijms25136814","journal-title":"Int J Mol Sci"},{"key":"4721_CR64","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.3390\/ijms23126582","volume":"23","author":"A Mart\u00ednez-Trejo","year":"2022","unstructured":"Mart\u00ednez-Trejo A, Ruiz-Ruiz JM, Gonzalez-Avila LU, Salda\u00f1a-Padilla A, Hern\u00e1ndez-Cortez C, Loyola-Cruz MA, Bello-L\u00f3pez JM, Castro-Escarpulli G (2022) Evasion of antimicrobial activity in Acinetobacter baumannii by target site modifications: an effective resistance mechanism. Int J Mol Sci 23:6582. https:\/\/doi.org\/10.3390\/ijms23126582","journal-title":"Int J Mol Sci"},{"key":"4721_CR65","doi-asserted-by":"publisher","first-page":"1178547","DOI":"10.3389\/fcimb.2023.1178547","volume":"13","author":"V Mattioni Marchetti","year":"2023","unstructured":"Mattioni Marchetti V, Hrabak J, Bitar I (2023) Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat. Front Cell Infect Microbiol 13:1178547. https:\/\/doi.org\/10.3389\/fcimb.2023.1178547","journal-title":"Front Cell Infect Microbiol"},{"key":"4721_CR66","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2217\/fmb-2023-0248","volume":"19","author":"SM McLeod","year":"2024","unstructured":"McLeod SM, O\u2019Donnell JP, Narayanan N, Mills JP, Kaye KS (2024) Sulbactam-durlobactam: a \u03b2-lactam\/\u03b2-lactamase inhibitor combination targeting Acinetobacter baumannii. Future Microbiol 19:563\u2013576. https:\/\/doi.org\/10.2217\/fmb-2023-0248","journal-title":"Future Microbiol"},{"key":"4721_CR67","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-981-99-2824-8_15","volume-title":"Plants for Immunity and Conservation Strategies","author":"S Mehra","year":"2023","unstructured":"Mehra S, Sharma VK, Tyagi C, Tomar LK (2023) Ethnomedicinal pertinence and antibacterial prospective of Himalayan medicinal plants of Uttarakhand in India. Plants for Immunity and Conservation Strategies. Springer, pp 311\u2013348"},{"key":"4721_CR68","doi-asserted-by":"publisher","first-page":"dlab188","DOI":"10.1093\/jacamr\/dlab188","volume":"3","author":"M Meschiari","year":"2021","unstructured":"Meschiari M, Volpi S, Faltoni M, Dolci G, Orlando G, Franceschini E, Menozzi M, Sarti M, Del Fabro G, Fumarola B, Guarneri F, Lanza P, Lorenzotti S, Saccani B, Signorini L, Van Hauwermeiren E, Gatti M, Pea F, Castelli F, Mussini C (2021) Real-life experience with compassionate use of Cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections. JAC Antimicrob Resist 3:dlab188. https:\/\/doi.org\/10.1093\/jacamr\/dlab188","journal-title":"JAC Antimicrob Resist"},{"key":"4721_CR69","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/antibiotics12020328","volume":"12","author":"C Michaelis","year":"2023","unstructured":"Michaelis C, Grohmann E (2023) Horizontal gene transfer of antibiotic resistance genes in biofilms. Antibiotics 12:328. https:\/\/doi.org\/10.3390\/antibiotics12020328","journal-title":"Antibiotics"},{"key":"4721_CR70","doi-asserted-by":"publisher","first-page":"20136","DOI":"10.1038\/s41598-021-99230-y","volume":"11","author":"MA Mohammed","year":"2021","unstructured":"Mohammed MA, Salim MTA, Anwer BE, Aboshanab KM, Aboulwafa MM (2021) Impact of target site mutations and plasmid-associated resistance genes acquisition on resistance of Acinetobacter baumannii to fluoroquinolones. Sci Rep 11:20136. https:\/\/doi.org\/10.1038\/s41598-021-99230-y","journal-title":"Sci Rep"},{"key":"4721_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2024.100331","volume":"8","author":"H Mukhopadhyay","year":"2024","unstructured":"Mukhopadhyay H, Bairagi A, Mukherjee A, Prasad AK, Roy AD, Nayak A (2024) Multidrug resistant Acinetobacter baumannii: a study on its pathogenesis and therapeutics. Curr Res Microb Sci 8:100331. https:\/\/doi.org\/10.1016\/j.crmicr.2024.100331","journal-title":"Curr Res Microb Sci"},{"key":"4721_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ph16111615","volume":"16","author":"G Muteeb","year":"2023","unstructured":"Muteeb G, Rehman MT, Shahwan M, Aatif M (2023) Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals 16:1615. https:\/\/doi.org\/10.3390\/ph16111615","journal-title":"Pharmaceuticals"},{"key":"4721_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100911","volume":"66","author":"V Naidu","year":"2023","unstructured":"Naidu V, Bartczak A, Brzoska AJ, Lewis P, Eijkelkamp BA, Paulsen IT, Elbourne LDH, Hassan KA (2023) Evolution of RND efflux pumps in the development of a successful pathogen. Drug Resist Updat 66:100911. https:\/\/doi.org\/10.1016\/j.drup.2022.100911","journal-title":"Drug Resist Updat"},{"key":"4721_CR74","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1111\/jam.15130","volume":"131","author":"M Nguyen","year":"2021","unstructured":"Nguyen M, Joshi SG (2021) Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review. J Appl Microbiol 131:2715\u20132738. https:\/\/doi.org\/10.1111\/jam.15130","journal-title":"J Appl Microbiol"},{"key":"4721_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125888","volume":"681","author":"B Ongoren","year":"2025","unstructured":"Ongoren B, Kara A, Serrano DR, Lalatsa A (2025) Novel enabling strategies for oral peptide delivery. Int J Pharm 125888. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125888","journal-title":"Int J Pharm"},{"key":"4721_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127679","volume":"283","author":"I Padhy","year":"2024","unstructured":"Padhy I, Dwibedy SK, Mohapatra SS (2024) A molecular overview of the polymyxin-LPS interaction in the context of its mode of action and resistance development. Microbiol Res 283:127679. https:\/\/doi.org\/10.1016\/j.micres.2024.127679","journal-title":"Microbiol Res"},{"key":"4721_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-33-6009-9","volume-title":"Introduction to Basics of Pharmacology and Toxicology, Volume 2: Essentials of Systemic Pharmacology\u2014From Principles to Practice.","author":"A Paul","year":"2021","unstructured":"Paul A, Anandabaskar N, Mathaiyan J, Raj GM (2021) Introduction to Basics of Pharmacology and Toxicology, Volume 2: Essentials of Systemic Pharmacology\u2014From Principles to Practice. Springer Nature. https:\/\/doi.org\/10.1007\/978-981-33-6009-9"},{"key":"4721_CR78","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1128\/AAC.04808-14","volume":"59","author":"WF Penwell","year":"2015","unstructured":"Penwell WF, Shapiro AB, Giacobbe RA, Gu RF, Gao N, Thresher J, McLaughlin RE, Huband MD, DeJonge BL, Ehmann DE, Miller AA (2015) Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii. Antimicrob Agents Chemother 59:1680\u20131689. https:\/\/doi.org\/10.1128\/AAC.04808-14","journal-title":"Antimicrob Agents Chemother"},{"key":"4721_CR79","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00745-22","volume":"13","author":"JB Rattray","year":"2022","unstructured":"Rattray JB, Thomas SA, Wang Y, Molotkova E, Gurney J, Varga JJ, Brown SP (2022) Bacterial quorum sensing allows graded and bimodal cellular responses to variations in population density. mBio 13:e0074522. https:\/\/doi.org\/10.1128\/mbio.00745-22","journal-title":"mBio"},{"key":"4721_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.793615","volume":"9","author":"S Roy","year":"2022","unstructured":"Roy S, Chowdhury G, Mukhopadhyay AK, Dutta S, Basu S (2022) Convergence of biofilm formation and antibiotic resistance in Acinetobacter baumannii infection. Front Med 9:793615. https:\/\/doi.org\/10.3389\/fmed.2022.793615","journal-title":"Front Med"},{"key":"4721_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04323-4","volume":"23","author":"A Saffari Natanzi","year":"2025","unstructured":"Saffari Natanzi A, Poudineh M, Karimi E, Khaledi A, Haddad Kashani H (2025) Innovative approaches to combat antibiotic resistance: integrating CRISPR\/Cas9 and nanoparticles against biofilm-driven infections. BMC Med 23:486. https:\/\/doi.org\/10.1186\/s12916-025-04323-4","journal-title":"BMC Med"},{"key":"4721_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11131946","volume":"11","author":"MA Salam","year":"2023","unstructured":"Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MAA (2023) Antimicrobial resistance: a growing serious threat for global public health. Healthcare 11:1946. https:\/\/doi.org\/10.3390\/healthcare11131946","journal-title":"Healthcare"},{"issue":"6","key":"4721_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13060506","volume":"13","author":"F Serapide","year":"2024","unstructured":"Serapide F, Guastalegname M, Gull\u00ec SP, Lionello R, Bruni A, Garofalo E, Longhini F, Trecarichi EM, Russo A (2024) Antibiotic treatment of carbapenem-resistant <Emphasis Type=\"Italic\">Acinetobacter baumannii<\/Emphasis> infections in view of the newly developed \u03b2-lactams: a narrative review of the existing evidence. Antibiotics 13(6):6. https:\/\/doi.org\/10.3390\/antibiotics13060506","journal-title":"Antibiotics"},{"key":"4721_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1053968","volume":"13","author":"A Shadan","year":"2023","unstructured":"Shadan A, Pathak A, Ma Y, Pathania R, Singh RP (2023) Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection. Front Cell Infect Microbiol 13:1053968. https:\/\/doi.org\/10.3389\/fcimb.2023.1053968","journal-title":"Front Cell Infect Microbiol"},{"key":"4721_CR85","doi-asserted-by":"crossref","unstructured":"Sharma S, Kaushik V, Kulshrestha M, Tiwari V (2023) Different efflux pump systems in Acinetobacter baumannii and their role in multidrug resistance. In: Donelli G (ed) Advances in Microbiology, Infectious Diseases and Public Health, Volume 17. Springer International Publishing, pp 155\u2013168","DOI":"10.1007\/5584_2023_771"},{"key":"4721_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11082115","volume":"11","author":"A Shelenkov","year":"2023","unstructured":"Shelenkov A, Akimkin V, Mikhaylova Y (2023) International clones of high risk of Acinetobacter baumannii\u2014definitions, history, properties and perspectives. Microorganisms 11:2115. https:\/\/doi.org\/10.3390\/microorganisms11082115","journal-title":"Microorganisms"},{"key":"4721_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1332108","volume":"15","author":"J Shi","year":"2024","unstructured":"Shi J, Cheng J, Liu S, Zhu Y, Zhu M (2024) Acinetobacter baumannii: an evolving and cunning opponent. Front Microbiol 15:1332108. https:\/\/doi.org\/10.3389\/fmicb.2024.1332108","journal-title":"Front Microbiol"},{"key":"4721_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32277-1","volume":"13","author":"S Shu","year":"2022","unstructured":"Shu S, Mi W (2022) Regulatory mechanisms of lipopolysaccharide synthesis in Escherichia coli. Nat Commun 13:4576. https:\/\/doi.org\/10.1038\/s41467-022-32277-1","journal-title":"Nat Commun"},{"key":"4721_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135253","volume":"279","author":"A Singh","year":"2024","unstructured":"Singh A, Tanwar M, Singh TP, Sharma S, Sharma P (2024) An escape from ESKAPE pathogens: a comprehensive review on current and emerging therapeutics against antibiotic resistance. Int J Biol Macromol 279:135253. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135253","journal-title":"Int J Biol Macromol"},{"key":"4721_CR90","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41579-023-00877-3","volume":"21","author":"WPJ Smith","year":"2023","unstructured":"Smith WPJ, Wucher BR, Nadell CD, Foster KR (2023) Bacterial defences: mechanisms, evolution and antimicrobial resistance. Nat Rev Microbiol 21:519\u2013534. https:\/\/doi.org\/10.1038\/s41579-023-00877-3","journal-title":"Nat Rev Microbiol"},{"key":"4721_CR91","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-021-00638-0","volume":"20","author":"J Sun","year":"2022","unstructured":"Sun J, Rutherford ST, Silhavy TJ, Huang KC (2022) Physical properties of the bacterial outer membrane. Nat Rev Microbiol 20:236\u2013248. https:\/\/doi.org\/10.1038\/s41579-021-00638-0","journal-title":"Nat Rev Microbiol"},{"key":"4721_CR92","doi-asserted-by":"publisher","first-page":"1141490","DOI":"10.3389\/fcimb.2023.1141490","volume":"13","author":"C Sun","year":"2023","unstructured":"Sun C, Yu Y, Hua X (2023) Resistance mechanisms of Tigecycline in Acinetobacter baumannii. Front Cell Infect Microbiol 13:1141490. https:\/\/doi.org\/10.3389\/fcimb.2023.1141490","journal-title":"Front Cell Infect Microbiol"},{"key":"4721_CR93","doi-asserted-by":"publisher","first-page":"590","DOI":"10.21608\/mid.2023.183097.1435","volume":"4","author":"MS Taha","year":"2023","unstructured":"Taha MS, Shoeib SM, Abdelwahab MA (2023) Mutations in GyrA and parc genes in fluoroquinolone-resistant Acinetobacter baumannii that causes hospital-acquired infection. Microbes Infect Dis 4:590\u2013600. https:\/\/doi.org\/10.21608\/mid.2023.183097.1435","journal-title":"Microbes Infect Dis"},{"key":"4721_CR94","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/microorganisms12071259","volume":"12","author":"L Tajer","year":"2024","unstructured":"Tajer L, Paillart JC, Dib H, Sabatier JM, Fajloun Z, Abi Khattar Z (2024) Molecular mechanisms of bacterial resistance to antimicrobial peptides in the modern era: an updated review. Microorganisms 12:1259. https:\/\/doi.org\/10.3390\/microorganisms12071259","journal-title":"Microorganisms"},{"key":"4721_CR95","volume-title":"Mechanistic studies of lipopolysaccharide transport in Gram-negative bacteria","author":"RJ Taylor","year":"2021","unstructured":"Taylor RJ (2021) Mechanistic studies of lipopolysaccharide transport in Gram-negative bacteria. Harvard University, Cambridge. https:\/\/dash.harvard.edu\/handle\/1\/37368522"},{"key":"4721_CR96","doi-asserted-by":"publisher","first-page":"175","DOI":"10.53854\/liim-3302-3","volume":"33","author":"I Terzi","year":"2025","unstructured":"Terzi I, Panagopoulos P, Rafailidis P (2025) Zosurabalpin: an antibiotic with a new mechanism of action against carbapenem-resistant Acinetobacter baumannii. Le Infezioni in Medicina 33:175\u2013181. https:\/\/doi.org\/10.53854\/liim-3302-3","journal-title":"Le Infezioni in Medicina"},{"key":"4721_CR97","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3390\/microorganisms12101978","volume":"12","author":"N Theodorakis","year":"2024","unstructured":"Theodorakis N, Feretzakis G, Hitas C, Kreouzi M, Kalantzi S, Spyridaki A, Boufeas IZ, Sakagianni A, Paxinou E, Verykios VS, Nikolaou M (2024) Antibiotic resistance in the elderly: Mechanisms, risk factors, and solutions. Microorganisms 12:1978. https:\/\/doi.org\/10.3390\/microorganisms12101978","journal-title":"Microorganisms"},{"key":"4721_CR98","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4137\/IDRT.S31567","volume":"9","author":"GS Tillotson","year":"2016","unstructured":"Tillotson GS (2016) Trojan horse antibiotics-a novel way to circumvent Gram-negative bacterial resistance? Infect Dis (Auckl) 9:45\u201352. https:\/\/doi.org\/10.4137\/IDRT.S31567","journal-title":"Infect Dis (Auckl)"},{"key":"4721_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodcont.2021.108004","volume":"125","author":"J Tong","year":"2021","unstructured":"Tong J, Zhang Z, Wu Q, Huang Z, Malakar PK, Chen L, Liu H, Pan Y, Zhao Y (2021) Antibacterial peptides from seafood: a promising weapon to combat bacterial hazards in food. Food Control 125:108004. https:\/\/doi.org\/10.1016\/j.foodcont.2021.108004","journal-title":"Food Control"},{"key":"4721_CR100","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/9783527698042","volume-title":"Surface-Functionalized Ceramics","author":"L Treccani","year":"2023","unstructured":"Treccani L (2023) Interactions between surface material and bacteria: From biofilm formation to suppression. Surface-Functionalized Ceramics. John Wiley & Sons, Ltd, pp 283\u2013335. https:\/\/doi.org\/10.1002\/9783527698042"},{"key":"4721_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8030375","volume":"8","author":"G Wareth","year":"2020","unstructured":"Wareth G, Brandt C, Sprague LD, Neubauer H, Pletz MW (2020) Spatio-temporal distribution of Acinetobacter baumannii in Germany-a comprehensive systematic review of studies on resistance development in humans (2000\u20132018). Microorganisms 8:375. https:\/\/doi.org\/10.3390\/microorganisms8030375","journal-title":"Microorganisms"},{"key":"4721_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10060690","volume":"10","author":"G Wareth","year":"2021","unstructured":"Wareth G, Linde J, Hammer P, Splettstoesser WD, Pletz MW, Neubauer H, Sprague LD (2021) Molecular characterization of German Acinetobacter baumannii isolates and multilocus sequence typing (MLST) analysis based on WGS reveals novel STs. Pathogens 10:690. https:\/\/doi.org\/10.3390\/pathogens10060690","journal-title":"Pathogens"},{"key":"4721_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.696","volume":"5","author":"Q Weng","year":"2024","unstructured":"Weng Q, Zhang F, Zheng Q (2024) Zosurabalpin: a novel tethered macrocyclic peptide antibiotic that kills carbapenem-resistant Acinetobacter baumannii. MedComm 5:e696. https:\/\/doi.org\/10.1002\/mco2.696","journal-title":"MedComm"},{"key":"4721_CR104","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10096-024-04991-9","volume":"44","author":"X Xu","year":"2025","unstructured":"Xu X, Meng L, Li J, Zhang Y, Liu B, Jiang W, Hao C (2025) Analysis of the potentially pathogenic bacteria of lower respiratory tract infections in children per-, during and post-COVID-19: a retrospective study. Eur J Clin Microbiol Infect Dis 44:167\u2013180. https:\/\/doi.org\/10.1007\/s10096-024-04991-9","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4721_CR105","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","volume":"41","author":"S Yaghoubi","year":"2022","unstructured":"Yaghoubi S, Zekiy AO, Krutova M, Gholami M, Kouhsari E, Sholeh M, Ghafouri Z, Maleki F (2022) Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. Eur J Clin Microbiol Infect Dis 41:1003\u20131022. https:\/\/doi.org\/10.1007\/s10096-020-04121-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4721_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1565965","volume":"16","author":"A Yehya","year":"2025","unstructured":"Yehya A, Ezzeddine Z, Chakkour M, Dhaini Z, Bou Saba MS, Bou Saba AS, Nohra L, Nassar NB, Yassine M, Bahmad HF, Ghssein G (2025) The intricacies of Acinetobacter baumannii: a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications. Front Microbiol 16:1565965. https:\/\/doi.org\/10.3389\/fmicb.2025.1565965","journal-title":"Front Microbiol"},{"key":"4721_CR107","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12275-024-00137-w","volume":"62","author":"Y Yoon","year":"2024","unstructured":"Yoon Y, Song S (2024) Structural insights into the lipopolysaccharide transport (Lpt) system as a novel antibiotic target. J Microbiol 62:261\u2013275. https:\/\/doi.org\/10.1007\/s12275-024-00137-w","journal-title":"J Microbiol"},{"key":"4721_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112532","volume":"12","author":"B Yousefi","year":"2024","unstructured":"Yousefi B, Kashanipoor S, Mazaheri P, Alibabaei F, Babaeizad A, Asli S, Mohammadi S, Gorgin AH, Alipour T, Oksenych V et al (2024) Cefiderocol in combating carbapenem-resistant Acinetobacter baumannii: action and resistance. Biomedicines 12:2532. https:\/\/doi.org\/10.3390\/biomedicines12112532","journal-title":"Biomedicines"},{"key":"4721_CR109","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/biomed4030026","volume":"4","author":"MJ Zai","year":"2024","unstructured":"Zai MJ, Cheesman MJ, Cock IE (2024) Targeted antimicrobial therapies: a solution to overcoming antimicrobial resistance in humans. BioMed Res Int 4:318\u2013337. https:\/\/doi.org\/10.3390\/biomed4030026","journal-title":"BioMed Res Int"},{"key":"4721_CR110","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-023-06873-0","volume":"625","author":"C Zampaloni","year":"2024","unstructured":"Zampaloni C, Mattei P, Bleicher K, Winther L, Th\u00e4te C, Bucher C, Adam JM, Alanine A, Amrein KE, Baidin V, Bieniossek C, Bissantz C, Boess F, Cantrill C, Clairfeuille T, Dey F, Di Giorgio P, du Castel P, Dylus D, Dzygiel Pawel, Felici Antonio, Garc\u00eda-Alcalde Fernando, Haldimann Andreas, Leipner Matthew, Leyn Semen, Louvel S\u00e9verine, Misson Pauline, Osterman Andrei, Pahil Karanbir, Rigo S\u00e9bastien, Sch\u00e4ublin Adrian, Scharf Sebastian, Schmitz Petra, Stoll Theodor, Trauner Andrej, Zoffmann Sannah, Kahne Daniel, Young John A. T., Lobritz Michael A., Bradley KA (2024) A novel antibiotic class targeting the lipopolysaccharide transporter. Nature 625:566\u2013571. https:\/\/doi.org\/10.1038\/s41586-023-06873-0","journal-title":"Nature"},{"key":"4721_CR111","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bsheal.2023.01.001","volume":"5","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang N, Wang M, Luo M, Peng Y, Li Z, Xu J, Ou M, Kan B, Li X, Lu X (2023) The prevalence and distribution of aminoglycoside resistance genes. Biosaf Health 5:14\u201320. https:\/\/doi.org\/10.1016\/j.bsheal.2023.01.001","journal-title":"Biosaf Health"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04721-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04721-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04721-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:59:58Z","timestamp":1774699198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04721-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4721"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04721-z","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This review article is a comprehensive analysis of existing literature and does not involve any experiments on humans, animals, or cell lines. Therefore, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"177"}}